Psychotic symptom and cannabis relapse in recent-onset psychosis. Prospective study
- PMID: 16880483
- DOI: 10.1192/bjp.bp.105.014308
Psychotic symptom and cannabis relapse in recent-onset psychosis. Prospective study
Abstract
Background: Cannabis use appears to exacerbate psychotic symptoms and increase risk of psychotic relapse. However, the relative contribution of cannabis use compared with other risk factors is unclear. The influence of psychotic symptoms on cannabis use has received little attention.
Aims: To examine the influence of cannabis use on psychotic symptom relapse and the influence of psychotic symptom severity on relapse in cannabis use in the 6 months following hospital admission.
Method: At baseline, 84 participants with recent-onset psychosis were assessed and 81 were followed up weekly for 6 months, using telephone and face-to-face interviews.
Results: A higher frequency of cannabis use was predictive of psychotic relapse, after controlling for medication adherence, other substance use and duration of untreated psychosis. An increase in psychotic symptoms was predictive of relapse to cannabis use, and medication adherence reduced cannabis relapse risk.
Conclusions: The relationship between cannabis use and psychosis may be bidirectional, highlighting the need for early intervention programmes to target cannabis use and psychotic symptom severity in this population.
Similar articles
-
The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study.Psychol Med. 2007 Jul;37(7):927-34. doi: 10.1017/S0033291707009956. Epub 2007 Feb 9. Psychol Med. 2007. PMID: 17288638
-
Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis.Lancet Psychiatry. 2017 Aug;4(8):627-633. doi: 10.1016/S2215-0366(17)30233-X. Epub 2017 Jul 10. Lancet Psychiatry. 2017. PMID: 28705600 Free PMC article.
-
The Effect of Changes in Cannabis Exposure on Psychotic Symptoms in Patients With Comorbid Cannabis Use Disorder.J Dual Diagn. 2016 Apr-Jun;12(2):129-36. doi: 10.1080/15504263.2016.1176426. Epub 2016 Apr 12. J Dual Diagn. 2016. PMID: 27070732
-
Antipsychotic treatment failure in patients with psychosis and co-morbid cannabis use: A systematic review.Psychiatry Res. 2019 Oct;280:112523. doi: 10.1016/j.psychres.2019.112523. Epub 2019 Aug 17. Psychiatry Res. 2019. PMID: 31450032
-
Cannabinoids and psychosis.Int Rev Psychiatry. 2009 Apr;21(2):152-62. doi: 10.1080/09540260902782802. Int Rev Psychiatry. 2009. PMID: 19367509 Review.
Cited by
-
Marijuana Use in the Era of Changing Cannabis Laws: What Are the Risks? Who is Most at Risk?Mo Med. 2018 Sep-Oct;115(5):398-404. Mo Med. 2018. PMID: 30385981 Free PMC article. Review.
-
Does change in cannabis use in established psychosis affect clinical outcome?Schizophr Bull. 2013 Mar;39(2):339-48. doi: 10.1093/schbul/sbr152. Epub 2011 Oct 29. Schizophr Bull. 2013. PMID: 22037770 Free PMC article. Clinical Trial.
-
A brain imaging study of dopamine receptor D2 availability in cannabis dependent users after recovery from cannabis-induced psychosis.Front Psychiatry. 2023 Oct 27;14:1230760. doi: 10.3389/fpsyt.2023.1230760. eCollection 2023. Front Psychiatry. 2023. PMID: 37965367 Free PMC article.
-
Utility of Washington Early Recognition Center Self-Report Screening Questionnaires in the Assessment of Patients with Schizophrenia and Bipolar Disorder.Front Psychiatry. 2016 Aug 26;7:149. doi: 10.3389/fpsyt.2016.00149. eCollection 2016. Front Psychiatry. 2016. PMID: 27616996 Free PMC article.
-
Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of Delta9-tetrahydrocannabinol.Psychopharmacology (Berl). 2007 Jun;192(3):325-36. doi: 10.1007/s00213-007-0721-3. Epub 2007 Feb 28. Psychopharmacology (Berl). 2007. PMID: 17333138
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical